Reneo Pharmaceuticals, Inc. (RPHM): Price and Financial Metrics
RPHM Price/Volume Stats
| Current price | $18.20 | 52-week high | $19.00 |
| Prev. close | $1.73 | 52-week low | $0.98 |
| Day low | $16.80 | Volume | 43,750 |
| Day high | $19.00 | Avg. volume | 250,384 |
| 50-day MA | $1.49 | Dividend yield | N/A |
| 200-day MA | $1.60 | Market Cap | 608.26M |
RPHM Stock Price Chart Interactive Chart >
Reneo Pharmaceuticals, Inc. (RPHM) Company Bio
Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. The company was incorporated in 2014 and is headquartered in San Diego, California.
RPHM Price Returns
| 1-mo | N/A |
| 3-mo | 17.42% |
| 6-mo | 9.64% |
| 1-year | -69.87% |
| 3-year | -78.91% |
| 5-year | N/A |
| YTD | 13.75% |
| 2023 | -31.33% |
| 2022 | -72.75% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...